Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ABM Therapeutics' ABM-1310 Granted Fast Track Designation by the FDA Following Orphan Drug Designation 2023-09-27 00:00
Latest Updates of Viva's Portfolio Companies 2023-09-26 21:06
China Jo-Jo Drugstores Announces $2.59 Million Registered Direct Offering 2023-09-26 21:00
Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design and provides general business update 2023-09-26 20:51
YS Biopharma Announces First Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine 2023-09-26 20:30
WuXi Vaccines Launches Its First Vaccines CDMO Site in China 2023-09-26 15:41
Ascletis Announces Completion of Enrollment of 120 Patients in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma 2023-09-26 08:10
Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology 2023-09-25 19:00
"Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery" 2023-09-25 15:31
Pierre Fabre Laboratories and Vernalis announce a drug discovery collaboration in oncology 2023-09-25 15:00
AffaMed Therapeutics Announces Clinical Trial Application Approval in Mainland China for Risuteganib (Luminate®) First-in-Class Candidate for the Treatment of Intermediate Dry AMD 2023-09-25 09:00
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC 2023-09-25 07:41
MediLink Therapeutics: Focuses on ADC research and development to promote new prospects for cancer treatment 2023-09-23 18:29
FDA Grants Fast Track Designation to 9MW3011 2023-09-22 08:00
Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function 2023-09-21 21:00
Golidocitinib Granted Priority Review by China NMPA for the Treatment of r/r PTCL 2023-09-21 20:26
AVANCE CLINICAL APPOINTS US-BASED EXECUTIVES - SVP SCIENTIFIC AND REGULATORY AFFAIRS, AND DIRECTOR BUSINESS DEVELOPMENT 2023-09-21 19:30
Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031 2023-09-21 18:05
Two Cases of Pancreatic Cancer Treatment with CARsgen's CT041 Published in Journal of Hematology & Oncology 2023-09-21 16:00
Yuyu Healthcare Conducts Global Promotion at Vitafoods Asia 2023 2023-09-21 14:06
1 78 79 80 81 82 413